- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Spyre Therapeutics appoints Kate Tansey Chevlen as Chief Commercial Officer | ||
| Fr | AstraZeneca and Daiichi Sankyo's Datroway given FDA Priority Review for breast cancer treatment | ||
| Fr | With compassion | ||
| Do | UCB announces new positive data on Bimzelx in hidradenitis suppurativa | ||
| Do | Sagimet announces positive results for Ascletis' denifanstat in moderate to severe acne | ||
| Do | ASH 2025: where Magic Kingdom met the spirit of Andor | ||
| Mi | AstraZeneca's Imfinzi regimen receives positive CHMP opinion for early gastric and gastroesophageal cancer | ||
| Mi | Sanofi's Rezurock receives positive CHMP opinion for chronic graft-versus-host disease | ||
| Mi | McNamara's Fallacy | ||
| Di | Johnson & Johnson's Darzalex Faspro regimen receives FDA approval for multiple myeloma | ||
| Di | Biogen's litifilimab receives FDA Breakthrough Therapy Designation for lupus | ||
| Di | Alzheimer's disease - the future of diagnosis and treatment in Europe | ||
| Mo | Boehringer Ingelheim and Simcere announce inflammatory bowel disease collaboration | ||
| Mo | Skyhawk Therapeutics' SKY-0515 shows positive results in Huntington's disease | ||
| Mo | Clinical trials on dementia: bridging access and innovation | ||
| 30.01. | Connecting through the chaos - why medical affairs needs creative problem-solving | ||
| 30.01. | AstraZeneca and CSPC Pharmaceuticals enter collaboration on weight management therapies | ||
| 30.01. | Genentech increases investment to $2bn for US manufacturing site | ||
| 29.01. | AstraZeneca announces $15bn investment in Chinese manufacturing and R&D by 2030 | ||
| 29.01. | GC Therapeutics appoints Kate Haviland as Board Chair | ||
| 29.01. | Genentech reports positive trial results for obesity treatment | ||
| 28.01. | Ipsen appoints Pierrick Lefranc as Executive Vice President Technical Operations | ||
| 28.01. | Novo Nordisk and Aspect Biosystems expand collaboration on diabetes research | ||
| 27.01. | Sanofi and Regeneron's Dupixent receives positive NICE final draft guidance for COPD | ||
| 27.01. | GSK's Arexvy RSV vaccine receives expanded EC approval for use in adults |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.